Flexion Therapeutics Inc (OQ:FLXN)

Business Focus: Bio Therapeutic Drugs

Latest 10 SEC filings (by transaction date) for FLXN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 19th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 14/19 Aug 13/19 Willwerth Christina Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,750  
Aug 14/19 Aug 13/19 Willwerth Christina Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $0.160
Aug 9/19 Aug 8/19 Colella Samuel D Indirect Ownership Common Stock P - Open market or private purchase 2,000 $10.74
Aug 8/19 Aug 8/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 2,317 $10.85
Jun 24/19 Jun 24/19 Clayman Michael D. Indirect Ownership Common Stock G - Gift 1,492  
Jun 24/19 Jun 24/19 Clayman Michael D. Direct Ownership Common Stock G - Gift -1,492  
Jun 24/19 Jun 21/19 Clayman Michael D. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,492 $9.81
Jun 24/19 Jun 21/19 Levine Mark S. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,213 $9.81
Jun 24/19 Jun 21/19 Wentworth Kerry Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 389 $9.81
Jun 24/19 Jun 21/19 Kelley Scott Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 2,152 $9.81
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for FLXN within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 19th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 14/19 Aug 13/19 Willwerth Christina Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -8,750  
Aug 14/19 Aug 13/19 Willwerth Christina Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,750 $0.160
Aug 9/19 Aug 8/19 Colella Samuel D Indirect Ownership Common Stock P - Open market or private purchase 2,000 $10.74
Aug 8/19 Aug 8/19 Clayman Michael D. Direct Ownership Common Stock P - Open market or private purchase 2,317 $10.85
Jun 24/19 Jun 24/19 Clayman Michael D. Indirect Ownership Common Stock G - Gift 1,492  
Jun 24/19 Jan 28/19 Clayman Michael D. Indirect Ownership Common Stock G - Gift 4,936  
Jun 24/19 Jun 24/19 Clayman Michael D. Direct Ownership Common Stock G - Gift -1,492  
Jun 24/19 Jun 21/19 Clayman Michael D. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,492 $9.81
Jun 24/19 Jan 28/19 Clayman Michael D. Direct Ownership Common Stock G - Gift -4,936  
Jun 24/19 Jun 21/19 Levine Mark S. Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,213 $9.81
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $FLXN

StockTwits